Press Release

Global Single Nucleotide Polymorphism Genotyping Market to grow with a CAGR of 17.20 %

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Single Nucleotide Polymorphism Genotyping Market.

According to TechSci Research report, “Global Single Nucleotide Polymorphism Genotyping Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Single Nucleotide Polymorphism Genotyping Market has valued at USD 8.15 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 17.20% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market. Advancements in genomic research have had a profound impact on Single Nucleotide Polymorphism (SNP) Genotyping. These developments have significantly improved the accuracy, throughput, and cost-effectiveness of SNP genotyping, making it a fundamental tool in the field of genomics. Genomic research has witnessed the development of high-throughput genotyping technologies. Researchers can now simultaneously genotype hundreds of thousands or even millions of SNPs in a single experiment, allowing for comprehensive studies of genetic variations across large populations. Genome-Wide Association Studies (GWAS) have become a standard approach in genomics research. These studies involve scanning the entire genome for SNPs associated with specific traits or diseases. The availability of extensive SNP genotyping arrays and data has facilitated the discovery of thousands of SNP-trait associations. The creation of extensive reference databases, such as the 1000 Genomes Project and the Genome Aggregation Database (gnomAD), has provided researchers with comprehensive catalogs of genetic variations, including SNPs. These databases serve as valuable resources for SNP selection and interpretation. The availability of Whole Genome Sequencing (WGS) data has allowed for the identification of rare and novel SNPs. Researchers can now delve deeper into the human genome and identify previously unknown genetic variants.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Single Nucleotide Polymorphism Genotyping Market

 

In February 2021, Thermo Fisher Scientific, the global leader in scientific solutions, has unveiled the Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel. This panel offers a customizable selection of 22 verified real-time PCR assays designed for the identification of SARS-CoV-2 mutations. These assays empower the monitoring of variants responsible for COVID-19 infections in specific regions worldwide and grant laboratories the flexibility to select the mutations they wish to track. Given the numerous mutations in SARS-CoV-2, some of which may affect the efficacy of treatments and vaccines, ongoing surveillance of viral changes is of paramount importance. The TaqMan SARS-CoV-2 Mutation Panel is highly adaptable, capable of analysing a small or large number of samples to identify one or multiple mutations. This versatility allows laboratories to meet varying testing requirements using the real-time PCR instruments they already have. The panel delivers results in approximately one hour and utilizes the reliable TaqMan SNP genotyping assay technology, ensuring efficient mutation detection and differentiation.

Interoperability is indeed a challenge in the Global Single Nucleotide Polymorphism (SNP) Genotyping Market. Interoperability refers to the ability of different SNP genotyping platforms, instruments, and data to work seamlessly together. The lack of interoperability can hinder the efficient exchange of genetic information, data analysis, and the integration of SNP genotyping results into broader research and healthcare contexts. There are various SNP genotyping platforms and technologies available, including microarrays, next-generation sequencing, real-time PCR, and others. These platforms often have proprietary data formats and analysis pipelines, making it challenging to integrate data from different sources. The absence of standardized data formats and reporting mechanisms can impede data sharing and collaboration. Different genotyping platforms may use unique data formats, which require conversion and compatibility efforts. Integrating SNP genotyping data with other types of biological and clinical data, such as gene expression data or electronic health records, can be complex due to issues of data format, quality, and the need for appropriate data management and integration tools.

Global Single Nucleotide Polymorphism Genotyping Market is segmented based on Technology, Application, and by region.

Based on the Technology, Global Single Nucleotide Polymorphism Genotyping Market is segmented into TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, Others. MassArray SNP genotyping, also known as MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) SNP genotyping, is a high-throughput method for identifying and characterizing single nucleotide polymorphisms (SNPs) in DNA samples. This technique is widely used in genetics and genomics research, clinical diagnostics, and various other applications. MassArray SNP genotyping is based on the principle of mass spectrometry, which involves the measurement of the mass-to-charge ratio (m/z) of ions. In this technique, each SNP is characterized by its unique mass signature. MassArray genotyping uses a matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass spectrometer to analyze the DNA samples.

Based on Region, North America held the largest share in the Global Single Nucleotide Polymorphism Genotyping Market. North America has been at the forefront of integrating genomics into clinical practice. Initiatives like the Precision Medicine Initiative in the United States have accelerated the adoption of SNP genotyping in healthcare for personalized medicine. The region's well-established healthcare infrastructure, including electronic health records and medical databases, facilitates the integration of genetic data into patient care and research. North America has a well-educated and skilled workforce in genomics, genetics, and biotechnology. Leading scientists, researchers, and experts in this field are based in the region.  The demand for SNP genotyping is high in North America due to a large patient population, a focus on understanding the genetic basis of diseases, and the need for advanced diagnostic and research tools.

Some of the major companies operating in the Global Single Nucleotide Polymorphism Genotyping Market include:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Douglas Scientific LLC
  • Illumina Inc.
  • Life Technologies Corp.
  • Luminex Corp
  •  Promega Corporation
  • Thermo Fischer Scientific Inc.
  • Fluidigm Corporation

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“Certain areas, particularly in North America, are projected to exert significant demand for Single Nucleotide Polymorphism Genotyping. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Single Nucleotide Polymorphism Genotyping Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Global Single Nucleotide Polymorphism Genotyping Market by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, Others), By Application (Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of Global Single Nucleotide Polymorphism Genotyping Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Single Nucleotide Polymorphism Genotyping Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News